Shots:
The US FDA approved 1 NDA in January 2024, leading to treatments for patients and advances in the healthcare industry
In January 2023, Zelsuvmi was approved by the US FDA for the Treatment of Molluscum Contagiosum
PharmaShots has compiled a list of US FDA-approved drugs in the month January 2024
1. Ligand Pharmaceuticals’ Zelsuvmi Receives…
Active Ingredient: bictegravir, emtricitabine, and tenofovir alafenamide
Strength: 50 mg of BIC, 200 mg of FTC, and 25 mg of TAF/ 30 mg of BIC, 120 mg of FTC, and 15 mg of TAF
Dosage Form: Tablet
Mechanism of Action: HIV reverse transcriptase inhibitors
First Approval: US (07 Feb 2018), EU (25 Jun 2018)
Revenue1
Gilead's HIV drug, Biktarvy has…

